Dark Matter

Agomab Therapeutics' CEO and 2 other insiders just bought $355K of their own stock in 16 days

Plus: an insider cluster at Rapport Therapeutics and $1.0M of buying at Agora since Sep 16.

DarkMatter Research
In 30 seconds
▸3 Agomab Therapeutics insiders bought $355K of stock in 16 days.
▸5 Rapport Therapeutics insiders bought $1.6M of stock in 1 days.
▸Insiders at 21 companies filed open-market purchases in the last four days.
▸Macro engine: 59/100, mixed. Growth, liquidity, volatility and positioning support risk; credit is balanced.
Macro engine  59/100  Mixed
Growth
▲
Liquidity
▲
Volatility
▲
Positioning
▲
Credit
•

Growth running at a 3.4% pace, money supply up 5.3% on the year and the VIX at 16.7.

▲ supports risk   ▼ weighs on it   • balanced

Insider cluster

AGMB  Three insiders at Agomab Therapeutics, including the CEO, put $355K of their own money into the stock over 16 days, and none of them has sold since. That is 0.08% of a company valued at $456.0M.

Who bought
David R Epstein
director
$175K
2 buys · avg $8.76 · last Oct 21
Tim Jasper Knotnerus
CEO
$94K
$8.58 · Oct 5
Pierre Thadee Victor Kemula
CFO
$86K
$8.59 · Oct 6

It is the first insider cluster at Agomab Therapeutics in three years.

AGMB is down 14% over the past month and 48% below its 52-week high of $17.82. The low was $8.23.

One insider buying can mean many things. Several at the same company, within weeks, with their own money, is the insider pattern with the strongest record in the research.

Insiders
3
Spent
$355K
Over
16 days
They paid
$8.67
Agomab Therapeutics price, past month
What to watch
The insiders' average price, about $8.67 a share, is the level to watch: AGMB is 7% above it at $9.26. Any new purchase has to be reported on a Form 4 within two business days.
Your call
Will AGMB close higher or lower than $9.26 on Friday, October 30?
HigherLower
One click to vote. We publish the results and the answer in Friday's issue.
How you called it

Will DX close higher or lower than $11.05 on Friday, October 23?

No votes were cast. We score it on Friday, October 23.

Also on the tape
Insider clusterMedium
RAPP  5 Rapport Therapeutics insiders bought $1.6M of stock in one day

5 insiders bought $1.6M in 1 days; none has sold since. They paid about $26.96 a share; the stock is at $26.53, 2% below their price.

Rapport Therapeutics price, past month
Insider buyingMedium
API  Agora's CEO has put $1.0M into the stock since Sep 16

They have bought Agora stock on 4 trading days since Sep 16, 247,129 shares for $1.0M in all, at an average of about $4.22. Before that, they had not bought in the open market in 3 years.

Agora price, past month
In the news
Oil Prices Hold Near $100 as Middle East Risks Offset Peace Hopes
OilPrice
Why Smart Investors Are Selling Oil Stocks and Buying MLPs
OilPrice
The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?
MarketWatch
Crowd mood

S&P 500 chatter: 26% of 2,329 posts negative, 13% positive, the gloomiest of the last 30 days.

Nasdaq-100 chatter: 33% of 1,872 posts negative, 16% positive, the gloomiest of the last 30 days.

Share of StockTwits, Reddit and news posts on each index that scored positive or negative today, against its own last 30 days. It describes the chatter; it is not a forecast.

Number of the day
$483K
put into Baozun by Wenbin Qiu since May 26
The signal board

New on the scan, not covered above

The scan found 58 signals across insider filings, CFTC positioning, FINRA dark-pool data, every engine's own history, congressional disclosures and Reddit. These are the new ones the story above does not cover.

Reddit attention 14
WDCWestern Digital
171 Reddit mentions in a day, up from 9
Low
MRNAModerna
160 Reddit mentions in a day, up from 25
Low
RNAAvidity Biosciences
50 Reddit mentions in a day, up from 1
Low
BEBloom Energy
125 Reddit mentions in a day, up from 21
Low
Risk-on or risk-off?
Mixed
The Dark Matter macro engine scores conditions 59 out of 100: conditions mixed / transitional. The economy is in an overheating phase, where growth and inflation are both running hot. 4 of 5 factor groups support risk-taking; none weighs on it.
 ▼ 59
Risk-offLeaning offMixedLeaning onRisk-on
Growth 64/100
Is the economy growing?
Real-time estimates put growth at a 3.4% annual pace.
Economic surprise index: surprise 2.0.
Credit in China is shrinking (-1.6% of GDP).
Supports risk
Liquidity 57/100
Is money flowing through the system?
Liquidity in the financial system is expanding.
Money supply is up 5.3% from a year ago.
10-year yields sit 0.32 points above 2-year yields.
Fed rate path: -2.1 cuts priced.
Supports risk
Volatility 61/100
How nervous are options traders?
VIX at 16.7, higher than on 43% of days in the past year.
Options insurance costs about what it usually does.
Options price a 7.4% chance of a 5% S&P 500 drop in the next week.
Supports risk
Positioning 59/100
Are trades crowded, and are markets trending?
Most markets are range-bound, not trending.
Supports risk
Credit 50/100
Are lenders and bond markets calm?
Financial conditions are balanced.
Corporate default risk is very low.
Balanced

Source: Dark Matter macro engine (the Oracle regime score), built from the terminal's growth, liquidity, volatility, credit and positioning engines; confidence 82%.

Learn
What is the COT report?

Every Friday the CFTC publishes who holds futures: hedgers (companies managing business risk) and speculators (funds betting on direction). When speculators pile into one side, the trade is crowded and can unwind quickly.

Get these signals the moment they fire
This letter is a once-a-day snapshot. The Dark Matter terminal tracks insider clusters, dark-pool volume, options flow and positioning live.
Open the terminal
How we rate signals
High: a validated insider cluster (several insiders buying within 30 days, no sales since), a CEO, CFO, president or chair buying on the open market, or two independent signals on one stock. Medium: a single insider purchase, a short-dated out-of-the-money options trade, or a 3-year positioning extreme in a major market. Low: dark-pool spikes on their own, and everything else.
Sources: SEC Form 4 filings, FINRA ATS data, CFTC Commitments of Traders, listed options volume and open interest, daily prices; via Dark Matter's engines.
Educational market commentary — not investment advice. DarkMatter Research is a publisher; everything here is for informational and educational purposes only, is general in nature, and is not personalized to any individual's financial situation. Nothing here is a recommendation to buy or sell any security. It is not connected to the management of any fund and does not reflect any fund's performance. Past market conditions do not predict future results. Consult your own licensed financial professional before making any investment decision.
The Daily Brief · Free · Every market morning

The signals worth knowing, before the open.

Insider cluster buys from SEC filings, unusual dark-pool volume from FINRA, big single-stock options bets and crowded futures positioning, each rated with one level to watch, plus where the terminal's macro engine puts risk-on or risk-off. Short, plain English, free. Educational market commentary, not investment advice.

No spam. Unsubscribe in one click. By subscribing you agree to our Privacy Policy.

More briefs

All issues →